Are there any long term concerns of having your stomach removed for stomach cancer?
Carolyn Vachani, RN, MSN, AOCN OncoLink Nurse Educator responds:
You can create a survivorship care plan to learn more at: www.livestrongcareplan.org
Removal of all (gastrectomy) or part of the stomach (partial gastrectomy) leads to changes in absorption of nutrients and digestion. Survivors should be followed by a dietician. Vitamin B12 is absorbed by the stomach and will need to be supplemented by injections of B12 once or twice a month for life. Survivors may require supplemental calcium, foliate and iron. When the stomach is removed, the esophagus is connected directly to the small bowel, changing the way food is digested. This will require the person to eat smaller, more frequent meals, with more proteins and fewer sugars and carbohydrates, to prevent complications such as nausea, vomiting and diarrhea. Dumping syndrome, nausea and abdominal cramping followed by diarrhea shortly after a meal, can also occur in survivors. This syndrome can be managed with dietary changes including eating small, frequent meals that are high in protein and low in carbohydrates, and taking-in minimal fluids while eating food so as to not flush out the food before nutrients are absorbed.
Heartburn or reflux may also be experienced by survivors especially early after treatment. It may be beneficial to remain in an upright sitting position for at least one hour after meals to help prevent reflux. Medications may also be beneficial in reducing reflux and maintaining esophageal health. Given the changes from surgery and other cancer treatment, survivors often have difficulty maintaining weight and getting adequate nutrition. A dietician can help with adapting to dietary changes, which can sometimes become less restrictive over time.
In addition, abdominal surgeries can put survivors at risk for bowel obstructions (due to scarring), hernia (due to cutting the abdominal muscle) and changes in bowel patterns. Radiation therapy to the abdomen and pelvis can increase the risk of these complications.
This question and answer was part of the OncoLink Brown Bag Chat Series. View the entire transcript from the Focus on GI Cancers webchat.
May 21, 2014 - A panel of three biomarkers together with CA 19-9 is better than CA 19-9 alone for diagnosing early-stage pancreatic cancer. These findings were presented at the American Association for Cancer Research's special conference on Pancreatic Cancer: Innovations in Research and Treatment, held from May 18 to 21 in New Orleans.
Feb 1, 2012
Sep 16, 2011